Soluble ST2 blood test for heart failure
Part of Heart & circulation clinical trials.
This trial is testing a simple blood test that measures a protein called soluble ST2, which may help doctors better understand heart failure. The goal is to see if this test can improve how heart failure is diagnosed or managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have signs or symptoms of heart failure, such as swelling in the neck veins or a shift in the heartbeat position.
- You must have a reduced, mildly reduced, or normal heart pumping function (ejection fraction less than 40%, 40–49%, or 50% or higher).
- You must not be in cardiogenic shock (a severe condition where the heart suddenly fails to pump enough blood).
- You must not have had a heart attack or acute coronary syndrome in the last 30 days.
- You must not have severe kidney disease (a glomerular filtration rate below 30) or interstitial pulmonary fibrosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart ultrasound method to measure stiffness in the heart muscle, which could help doctors diagnose a type of heart failure where the heart is stiff but still squeezes normally. It is for elderly patients with heart failure, and the findings might lead to a simpler and safer way to identify this condition.
This study looks at how stiff your arteries are and how well your blood vessels work in people with heart failure. It might help doctors understand heart failure better and find new ways to treat it.
This trial is looking at whether a blood test can help doctors choose the best treatment for people with heart disease who are getting stents. It may help make treatment more personal and effective.
This study uses simple heart tests and blood markers to sort people with chronic heart failure into different risk levels, which may help guide treatment. You may join if you have heart failure symptoms and certain test findings.
This study looks at whether certain new blood tests (biomarkers) can help doctors learn more about chronic heart failure. You might be asked for blood samples and health information, and the results could improve how heart failure is understood in the future.
This study looks at using a blood test to find early signs that heart failure may be getting worse. It aims to help doctors provide better care after a hospital stay.
Hear when a new Heart Failure Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.